世界の運動ニューロン病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Motor Neuron Diseases Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3924
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、運動ニューロン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リルゾール、ヌシネルセン、理学療法、呼吸療法、その他）、用途別市場規模（総合クリニック、病院、社会福祉施設、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・運動ニューロン病治療の市場動向
・企業の競争状況、市場シェア
・運動ニューロン病治療の種類別市場規模（リルゾール、ヌシネルセン、理学療法、呼吸療法、その他）
・運動ニューロン病治療の用途別市場規模（総合クリニック、病院、社会福祉施設、その他）
・運動ニューロン病治療の北米市場規模2016-2027（アメリカ、カナダ）
・運動ニューロン病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・運動ニューロン病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・運動ニューロン病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・運動ニューロン病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（NIH、UCL Institute of Neurology、National Neuroscience Institute、The University of Melbourne、The University of Sheffield、OZBiosciences、The University of Queensland、MND Australia）
・結論

Market Analysis and Insights: Global Motor Neuron Diseases Treatment Market
The global Motor Neuron Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Motor Neuron Diseases Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Motor Neuron Diseases Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Motor Neuron Diseases Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Motor Neuron Diseases Treatment market.

Global Motor Neuron Diseases Treatment Scope and Market Size
Motor Neuron Diseases Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Motor Neuron Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Riluzole
Nusinersen
Physical Therapy
Respiratory Therapy
Others

Segment by Application
Multidisciplinary Clinics
Hospitals
Social Work Facilities
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
NIH
UCL Institute of Neurology
National Neuroscience Institute
The University of Melbourne
The University of Sheffield
OZBiosciences
The University of Queensland
MND Australia

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Motor Neuron Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Riluzole
1.2.3 Nusinersen
1.2.4 Physical Therapy
1.2.5 Respiratory Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Motor Neuron Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Multidisciplinary Clinics
1.3.3 Hospitals
1.3.4 Social Work Facilities
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Motor Neuron Diseases Treatment Market Perspective (2016-2027)
2.2 Motor Neuron Diseases Treatment Growth Trends by Regions
2.2.1 Motor Neuron Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Motor Neuron Diseases Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Motor Neuron Diseases Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Motor Neuron Diseases Treatment Industry Dynamic
2.3.1 Motor Neuron Diseases Treatment Market Trends
2.3.2 Motor Neuron Diseases Treatment Market Drivers
2.3.3 Motor Neuron Diseases Treatment Market Challenges
2.3.4 Motor Neuron Diseases Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Motor Neuron Diseases Treatment Players by Revenue
3.1.1 Global Top Motor Neuron Diseases Treatment Players by Revenue (2016-2021)
3.1.2 Global Motor Neuron Diseases Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Motor Neuron Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Motor Neuron Diseases Treatment Revenue
3.4 Global Motor Neuron Diseases Treatment Market Concentration Ratio
3.4.1 Global Motor Neuron Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Motor Neuron Diseases Treatment Revenue in 2020
3.5 Motor Neuron Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Motor Neuron Diseases Treatment Product Solution and Service
3.7 Date of Enter into Motor Neuron Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Motor Neuron Diseases Treatment Breakdown Data by Type
4.1 Global Motor Neuron Diseases Treatment Historic Market Size by Type (2016-2021)
4.2 Global Motor Neuron Diseases Treatment Forecasted Market Size by Type (2022-2027)

5 Motor Neuron Diseases Treatment Breakdown Data by Application
5.1 Global Motor Neuron Diseases Treatment Historic Market Size by Application (2016-2021)
5.2 Global Motor Neuron Diseases Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Motor Neuron Diseases Treatment Market Size (2016-2027)
6.2 North America Motor Neuron Diseases Treatment Market Size by Type
6.2.1 North America Motor Neuron Diseases Treatment Market Size by Type (2016-2021)
6.2.2 North America Motor Neuron Diseases Treatment Market Size by Type (2022-2027)
6.2.3 North America Motor Neuron Diseases Treatment Market Size by Type (2016-2027)
6.3 North America Motor Neuron Diseases Treatment Market Size by Application
6.3.1 North America Motor Neuron Diseases Treatment Market Size by Application (2016-2021)
6.3.2 North America Motor Neuron Diseases Treatment Market Size by Application (2022-2027)
6.3.3 North America Motor Neuron Diseases Treatment Market Size by Application (2016-2027)
6.4 North America Motor Neuron Diseases Treatment Market Size by Country
6.4.1 North America Motor Neuron Diseases Treatment Market Size by Country (2016-2021)
6.4.2 North America Motor Neuron Diseases Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Motor Neuron Diseases Treatment Market Size (2016-2027)
7.2 Europe Motor Neuron Diseases Treatment Market Size by Type
7.2.1 Europe Motor Neuron Diseases Treatment Market Size by Type (2016-2021)
7.2.2 Europe Motor Neuron Diseases Treatment Market Size by Type (2022-2027)
7.2.3 Europe Motor Neuron Diseases Treatment Market Size by Type (2016-2027)
7.3 Europe Motor Neuron Diseases Treatment Market Size by Application
7.3.1 Europe Motor Neuron Diseases Treatment Market Size by Application (2016-2021)
7.3.2 Europe Motor Neuron Diseases Treatment Market Size by Application (2022-2027)
7.3.3 Europe Motor Neuron Diseases Treatment Market Size by Application (2016-2027)
7.4 Europe Motor Neuron Diseases Treatment Market Size by Country
7.4.1 Europe Motor Neuron Diseases Treatment Market Size by Country (2016-2021)
7.4.2 Europe Motor Neuron Diseases Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Motor Neuron Diseases Treatment Market Size (2016-2027)
8.2 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Type
8.2.1 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Application
8.3.1 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Region
8.4.1 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Motor Neuron Diseases Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Motor Neuron Diseases Treatment Market Size (2016-2027)
9.2 Latin America Motor Neuron Diseases Treatment Market Size by Type
9.2.1 Latin America Motor Neuron Diseases Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Motor Neuron Diseases Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Motor Neuron Diseases Treatment Market Size by Type (2016-2027)
9.3 Latin America Motor Neuron Diseases Treatment Market Size by Application
9.3.1 Latin America Motor Neuron Diseases Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Motor Neuron Diseases Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Motor Neuron Diseases Treatment Market Size by Application (2016-2027)
9.4 Latin America Motor Neuron Diseases Treatment Market Size by Country
9.4.1 Latin America Motor Neuron Diseases Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Motor Neuron Diseases Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Motor Neuron Diseases Treatment Market Size (2016-2027)
10.2 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Type
10.2.1 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Application
10.3.1 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Country
10.4.1 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Motor Neuron Diseases Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 NIH
11.1.1 NIH Company Details
11.1.2 NIH Business Overview
11.1.3 NIH Motor Neuron Diseases Treatment Introduction
11.1.4 NIH Revenue in Motor Neuron Diseases Treatment Business (2016-2021)
11.1.5 NIH Recent Development
11.2 UCL Institute of Neurology
11.2.1 UCL Institute of Neurology Company Details
11.2.2 UCL Institute of Neurology Business Overview
11.2.3 UCL Institute of Neurology Motor Neuron Diseases Treatment Introduction
11.2.4 UCL Institute of Neurology Revenue in Motor Neuron Diseases Treatment Business (2016-2021)
11.2.5 UCL Institute of Neurology Recent Development
11.3 National Neuroscience Institute
11.3.1 National Neuroscience Institute Company Details
11.3.2 National Neuroscience Institute Business Overview
11.3.3 National Neuroscience Institute Motor Neuron Diseases Treatment Introduction
11.3.4 National Neuroscience Institute Revenue in Motor Neuron Diseases Treatment Business (2016-2021)
11.3.5 National Neuroscience Institute Recent Development
11.4 The University of Melbourne
11.4.1 The University of Melbourne Company Details
11.4.2 The University of Melbourne Business Overview
11.4.3 The University of Melbourne Motor Neuron Diseases Treatment Introduction
11.4.4 The University of Melbourne Revenue in Motor Neuron Diseases Treatment Business (2016-2021)
11.4.5 The University of Melbourne Recent Development
11.5 The University of Sheffield
11.5.1 The University of Sheffield Company Details
11.5.2 The University of Sheffield Business Overview
11.5.3 The University of Sheffield Motor Neuron Diseases Treatment Introduction
11.5.4 The University of Sheffield Revenue in Motor Neuron Diseases Treatment Business (2016-2021)
11.5.5 The University of Sheffield Recent Development
11.6 OZBiosciences
11.6.1 OZBiosciences Company Details
11.6.2 OZBiosciences Business Overview
11.6.3 OZBiosciences Motor Neuron Diseases Treatment Introduction
11.6.4 OZBiosciences Revenue in Motor Neuron Diseases Treatment Business (2016-2021)
11.6.5 OZBiosciences Recent Development
11.7 The University of Queensland
11.7.1 The University of Queensland Company Details
11.7.2 The University of Queensland Business Overview
11.7.3 The University of Queensland Motor Neuron Diseases Treatment Introduction
11.7.4 The University of Queensland Revenue in Motor Neuron Diseases Treatment Business (2016-2021)
11.7.5 The University of Queensland Recent Development
11.8 MND Australia
11.8.1 MND Australia Company Details
11.8.2 MND Australia Business Overview
11.8.3 MND Australia Motor Neuron Diseases Treatment Introduction
11.8.4 MND Australia Revenue in Motor Neuron Diseases Treatment Business (2016-2021)
11.8.5 MND Australia Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Motor Neuron Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Riluzole
Table 3. Key Players of Nusinersen
Table 4. Key Players of Physical Therapy
Table 5. Key Players of Respiratory Therapy
Table 6. Key Players of Others
Table 7. Global Motor Neuron Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Motor Neuron Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Motor Neuron Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Motor Neuron Diseases Treatment Market Share by Regions (2016-2021)
Table 11. Global Motor Neuron Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Motor Neuron Diseases Treatment Market Share by Regions (2022-2027)
Table 13. Motor Neuron Diseases Treatment Market Trends
Table 14. Motor Neuron Diseases Treatment Market Drivers
Table 15. Motor Neuron Diseases Treatment Market Challenges
Table 16. Motor Neuron Diseases Treatment Market Restraints
Table 17. Global Motor Neuron Diseases Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Motor Neuron Diseases Treatment Market Share by Players (2016-2021)
Table 19. Global Top Motor Neuron Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motor Neuron Diseases Treatment as of 2020)
Table 20. Ranking of Global Top Motor Neuron Diseases Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Motor Neuron Diseases Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Motor Neuron Diseases Treatment Product Solution and Service
Table 24. Date of Enter into Motor Neuron Diseases Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Motor Neuron Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Motor Neuron Diseases Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Motor Neuron Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Motor Neuron Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Motor Neuron Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Motor Neuron Diseases Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Motor Neuron Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Motor Neuron Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Motor Neuron Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Motor Neuron Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Motor Neuron Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Motor Neuron Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Motor Neuron Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Motor Neuron Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Motor Neuron Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Motor Neuron Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Motor Neuron Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Motor Neuron Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Motor Neuron Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Motor Neuron Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Motor Neuron Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Motor Neuron Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Motor Neuron Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Motor Neuron Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Motor Neuron Diseases Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Motor Neuron Diseases Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Motor Neuron Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Motor Neuron Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Motor Neuron Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Motor Neuron Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Motor Neuron Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Motor Neuron Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Motor Neuron Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Motor Neuron Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Motor Neuron Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Motor Neuron Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Motor Neuron Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Motor Neuron Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. NIH Company Details
Table 65. NIH Business Overview
Table 66. NIH Motor Neuron Diseases Treatment Product
Table 67. NIH Revenue in Motor Neuron Diseases Treatment Business (2016-2021) & (US$ Million)
Table 68. NIH Recent Development
Table 69. UCL Institute of Neurology Company Details
Table 70. UCL Institute of Neurology Business Overview
Table 71. UCL Institute of Neurology Motor Neuron Diseases Treatment Product
Table 72. UCL Institute of Neurology Revenue in Motor Neuron Diseases Treatment Business (2016-2021) & (US$ Million)
Table 73. UCL Institute of Neurology Recent Development
Table 74. National Neuroscience Institute Company Details
Table 75. National Neuroscience Institute Business Overview
Table 76. National Neuroscience Institute Motor Neuron Diseases Treatment Product
Table 77. National Neuroscience Institute Revenue in Motor Neuron Diseases Treatment Business (2016-2021) & (US$ Million)
Table 78. National Neuroscience Institute Recent Development
Table 79. The University of Melbourne Company Details
Table 80. The University of Melbourne Business Overview
Table 81. The University of Melbourne Motor Neuron Diseases Treatment Product
Table 82. The University of Melbourne Revenue in Motor Neuron Diseases Treatment Business (2016-2021) & (US$ Million)
Table 83. The University of Melbourne Recent Development
Table 84. The University of Sheffield Company Details
Table 85. The University of Sheffield Business Overview
Table 86. The University of Sheffield Motor Neuron Diseases Treatment Product
Table 87. The University of Sheffield Revenue in Motor Neuron Diseases Treatment Business (2016-2021) & (US$ Million)
Table 88. The University of Sheffield Recent Development
Table 89. OZBiosciences Company Details
Table 90. OZBiosciences Business Overview
Table 91. OZBiosciences Motor Neuron Diseases Treatment Product
Table 92. OZBiosciences Revenue in Motor Neuron Diseases Treatment Business (2016-2021) & (US$ Million)
Table 93. OZBiosciences Recent Development
Table 94. The University of Queensland Company Details
Table 95. The University of Queensland Business Overview
Table 96. The University of Queensland Motor Neuron Diseases Treatment Product
Table 97. The University of Queensland Revenue in Motor Neuron Diseases Treatment Business (2016-2021) & (US$ Million)
Table 98. The University of Queensland Recent Development
Table 99. MND Australia Company Details
Table 100. MND Australia Business Overview
Table 101. MND Australia Revenue in Motor Neuron Diseases Treatment Business (2016-2021) & (US$ Million)
Table 102. MND Australia Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Motor Neuron Diseases Treatment Market Share by Type: 2020 VS 2027
Figure 2. Riluzole Features
Figure 3. Nusinersen Features
Figure 4. Physical Therapy Features
Figure 5. Respiratory Therapy Features
Figure 6. Others Features
Figure 7. Global Motor Neuron Diseases Treatment Market Share by Application: 2020 VS 2027
Figure 8. Multidisciplinary Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Social Work Facilities Case Studies
Figure 11. Others Case Studies
Figure 12. Motor Neuron Diseases Treatment Report Years Considered
Figure 13. Global Motor Neuron Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Motor Neuron Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Motor Neuron Diseases Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Motor Neuron Diseases Treatment Market Share by Regions (2022-2027)
Figure 17. Global Motor Neuron Diseases Treatment Market Share by Players in 2020
Figure 18. Global Top Motor Neuron Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Motor Neuron Diseases Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Motor Neuron Diseases Treatment Revenue in 2020
Figure 20. Global Motor Neuron Diseases Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Motor Neuron Diseases Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Motor Neuron Diseases Treatment Market Share by Type (2016-2027)
Figure 24. North America Motor Neuron Diseases Treatment Market Share by Application (2016-2027)
Figure 25. North America Motor Neuron Diseases Treatment Market Share by Country (2016-2027)
Figure 26. United States Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Motor Neuron Diseases Treatment Market Share by Type (2016-2027)
Figure 30. Europe Motor Neuron Diseases Treatment Market Share by Application (2016-2027)
Figure 31. Europe Motor Neuron Diseases Treatment Market Share by Country (2016-2027)
Figure 32. Germany Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Motor Neuron Diseases Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Motor Neuron Diseases Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Motor Neuron Diseases Treatment Market Share by Region (2016-2027)
Figure 42. China Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Motor Neuron Diseases Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Motor Neuron Diseases Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Motor Neuron Diseases Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Motor Neuron Diseases Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Motor Neuron Diseases Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Motor Neuron Diseases Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Motor Neuron Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. NIH Revenue Growth Rate in Motor Neuron Diseases Treatment Business (2016-2021)
Figure 62. UCL Institute of Neurology Revenue Growth Rate in Motor Neuron Diseases Treatment Business (2016-2021)
Figure 63. National Neuroscience Institute Revenue Growth Rate in Motor Neuron Diseases Treatment Business (2016-2021)
Figure 64. The University of Melbourne Revenue Growth Rate in Motor Neuron Diseases Treatment Business (2016-2021)
Figure 65. The University of Sheffield Revenue Growth Rate in Motor Neuron Diseases Treatment Business (2016-2021)
Figure 66. OZBiosciences Revenue Growth Rate in Motor Neuron Diseases Treatment Business (2016-2021)
Figure 67. The University of Queensland Revenue Growth Rate in Motor Neuron Diseases Treatment Business (2016-2021)
Figure 68. MND Australia Revenue Growth Rate in Motor Neuron Diseases Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の感染性疾患治療市場規模・現状・予測（2021年-2027年）

Global Communicable Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1490 2021年4月 93Pages
QYResearch社発行の本調査資料では、感染性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の伝染病治療市場規模・現状・予測（2021年-2027年）

Global Treatment for Communicable Diseases Market Size, Status and Forecast 2021-2027
QYR2104Z5738 2021年4月 96Pages
QYResearch社発行の本調査資料では、伝染病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の孤児肺疾患治療市場規模・現状・予測（2021年-2027年）

Global Orphan Lung Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4327 2021年4月 92Pages
QYResearch社発行の本調査資料では、孤児肺疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症剤、抗線維化剤、血管拡張剤、コルチコステロイド、CFTRモジュレーター、その他）、用途別市場規模（病院薬局、ドラッグスト...

世界の豚病気治療市場規模・現状・予測（2021年-2027年）

Global Swine Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5522 2021年4月 96Pages
QYResearch社発行の本調査資料では、豚病気治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（滲出性皮膚炎、コクシジウム症、呼吸器疾患、豚赤痢、乳腺炎、ブタパルボウイルス）、用途別市場規模（私立獣医病院、私立獣医薬局、政府獣医クリニック...

世界の慢性肺疾患治療市場規模・現状・予測（2021年-2027年）

Global Chronic Lung Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1319 2021年4月 96Pages
QYResearch社発行の本調査資料では、慢性肺疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、カプセル、錠剤、その他）、用途別市場規模（気管支肺異形成症、喘息、COPD、肺線維症）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の原発性免疫不全症治療市場規模・現状・予測（2021年-2027年）

Global Primary Immunodeficiency Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4789 2021年4月 95Pages
QYResearch社発行の本調査資料では、原発性免疫不全症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫グロブリン療法、抗生物質、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の免疫性炎症性疾患治療市場規模・現状・予測（2021年-2027年）

Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3045 2021年4月 90Pages
QYResearch社発行の本調査資料では、免疫性炎症性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物学的療法、新規療法）、用途別市場規模（病院、薬局、オンライン薬局ストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の筋骨格系疾患治療市場規模・現状・予測（2021年-2027年）

Global Musculoskeletal Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3973 2021年4月 99Pages
QYResearch社発行の本調査資料では、筋骨格系疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（磁気共鳴画像法（MRI）、コンピューター断層撮影（CT）、超音波、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0522 2021年4月 98Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（輸血、サプリメント、医薬品、理学療法、その他）、用途別市場規模（病院、医療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の肝疾患治療市場規模・現状・予測（2021年-2027年）

Global Liver Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3455 2021年4月 159Pages
QYResearch社発行の本調査資料では、肝疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法薬、標的療法、抗ウイルス薬、免疫グロブリン、コルチコステロイド、ワクチン、抗拒絶薬/免疫抑制剤）、用途別市場規模（がん、肝炎、肝硬変症...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Diseases Treatment Market The global Autoimmune Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
世界の原発性免疫不全症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Immunodeficiency Diseases Treatment Market The global Primary Immunodeficiency Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in …
世界の豚病気治療市場規模・現状・予測（2021年-2027年） Swine diseases treatments help in improving health, increase production of livestock and prevent transmission of diseases among animals in a cost effective manner. The global swine diseases treatment market is driven by factors such as rapid changing pattern of diseases among the animals. Market Ana…
世界の伝染病治療市場規模・現状・予測（2021年-2027年） In this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites Market Analysis and Insights: Global Treatment for Communicable Diseases Market The global Treatment for Communicable Diseases market s…
世界の感染性疾患治療市場規模・現状・予測（2021年-2027年） In this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites Market Analysis and Insights: Global Communicable Diseases Treatment Market The global Communicable Diseases Treatment market size is p…